Adding Vortexing to the Maki Technique Provides no Benefit for the Diagnosis of Catheter-related Bacteremia
1 other identifier
observational
136
1 country
1
Brief Summary
The investigators wanted to determine whether the combined use of vortexing and Maki techniques provides profitability versus the Maki technique for the diagnosis of catheter tip colonization and catheter-related bloodstream infection
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P50-P75 for all trials
Started Apr 2022
Shorter than P25 for all trials
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
April 1, 2022
CompletedPrimary Completion
Last participant's last visit for primary outcome
September 30, 2022
CompletedStudy Completion
Last participant's last visit for all outcomes
September 30, 2022
CompletedFirst Submitted
Initial submission to the registry
January 9, 2024
CompletedFirst Posted
Study publicly available on registry
January 22, 2024
CompletedJanuary 22, 2024
January 1, 2024
6 months
January 9, 2024
January 19, 2024
Conditions
Outcome Measures
Primary Outcomes (1)
diagnosis of catheter related bloodstream infection
Number of patients with vortexing and/or Maki technique positive
6 months
Study Arms (1)
CRI
Patients with suspected catheter-related infection (CRI) and with one central venous catheter for at least 7 days were included. The area under the curve (AUC) of the Maki technique, the vortexing technique and the combination of both techniques for the diagnosis of catheter tip colonization (CTC) and diagnosis of catheter-related bloodstream infection (CRBSI) were compared.
Interventions
Eligibility Criteria
Patient recruitment was performed in the Intensive Care Unit
You may qualify if:
- Patients with suspicion of catheter-related infection (CRI) and with long term CVC (at least 7 days)
You may not qualify if:
- none
Contact the study team to confirm eligibility.
Sponsors & Collaborators
Study Sites (1)
Leonardo Lorente
San Cristóbal de La Laguna, Tenerife, 38320, Spain
Study Design
- Study Type
- observational
- Observational Model
- COHORT
- Time Perspective
- PROSPECTIVE
- Sponsor Type
- OTHER
- Responsible Party
- PRINCIPAL INVESTIGATOR
- PI Title
- Medical assistant
Study Record Dates
First Submitted
January 9, 2024
First Posted
January 22, 2024
Study Start
April 1, 2022
Primary Completion
September 30, 2022
Study Completion
September 30, 2022
Last Updated
January 22, 2024
Record last verified: 2024-01
Data Sharing
- IPD Sharing
- Will not share
The study is completed